Sponsor:
Pfizer
Code:
NCT05090566
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elranatamab + Nirogacestat
Elranatamab + lenalidomide + dexamethasone
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Pfizer on 2025-04-15.